NextMeds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: flat-price compounded GLP-1 bundled with a care coach and dietitian
NextMeds scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
NextMeds is a cash-pay telehealth platform offering compounded semaglutide and compounded tirzepatide on a flat monthly membership — one price bundling the medication (if prescribed), telehealth visits, a 1:1 care coach, and a licensed registered dietitian, with free shipping and no insurance. A licensed provider reviews a free online assessment (with a live video or phone consult where a state requires it) and prescribes if appropriate; medication ships from a licensed compounding pharmacy in the Next Meds network. Available in all 50 states; cancel anytime with no auto-renewal.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to NextMeds
DudeMeds
Best for: men seeking no-fee GLP-1 access with oral and injectable options
Editorial score · methodology
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
NextMeds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $129/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping · Coaching
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored NextMeds
Each dimension is scored algorithmically from NextMeds’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.6/10At $129/mo, NextMeds runs about 24% below the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.2/10NextMeds offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.5/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
6.4/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-08-02).
Accessibility10%
7.8/10NextMeds treats patients in all 50 states. FSA/HSA cards are accepted.
Support10%
6.9/10Coaching/dietitian access included.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this NextMeds review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with NextMeds
We walked NextMeds’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Start a free, no-obligation online assessment sharing your health information and goals.
- 2A licensed provider reviews your assessment; where your state requires it, a live video or phone consult is completed before any prescription.
- 3If appropriate, the provider prescribes and your medication ships to your door from a licensed compounding pharmacy in the Next Meds network.
- 4Continue on a flat monthly membership with a 1:1 care coach and registered dietitian; cancel anytime, no auto-renewal.
- Flat membership pricing is shown before intake: compounded semaglutide $129/month and compounded tirzepatide $179/month, 'same price every dose' with no hidden fees.
- One price bundles the medication (if prescribed), telehealth visits, free shipping, a 1:1 care coach and a licensed registered dietitian; no insurance required, FSA eligible.
- The homepage runs an active promotion ('starting at $100/mo', a countdown timer and an 'offer ends July 30' banner) with a 'price increases' warning, so pricing may be promotional.
- Cancel anytime with no auto-renewal; a refund and cancellation policy is linked.
- NextMeds describes itself as a technology platform coordinating care with affiliated providers and pharmacies (Foothills Pharmacy named), not the medical provider; individual clinicians are not named.
- Services all 50 states; a LegitScript 'approval' is claimed but only via a generic directory link, not a verifiable seal.
NextMeds customer support
- care@nextmeds.com
GLP-1 medications NextMeds offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Compounded Semaglutide Membership — flat, same price every dose; bundles telehealth visits, care coach, dietitian and shipping. An active promo ('starting at $100/mo', countdown timer) may lower the intro price.
Compounded Tirzepatide Membership — flat, same price every dose; bundles telehealth visits, care coach, dietitian and shipping. An active promo may lower the intro price.
Ready to get started?
Plans and promotions change often — check NextMeds's current pricing and active discounts before you decide.
What we like
- Flat monthly membership bundles the medication, telehealth visits, a 1:1 care coach and a licensed registered dietitian — one price, no hidden fees
- Same price every dose, no auto-renewal, cancel anytime; free shipping and no insurance needed (FSA eligible)
- Names a compounding pharmacy partner (Foothills Pharmacy) and states it services all 50 states
- Free, no-obligation online assessment before you pay anything
Watch-outs
- Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it
- Promo-driven pricing with a countdown timer and 'price increases' urgency; the standing membership is $129 (sema) / $179 (tirz)
- A technology platform that coordinates care, not the medical provider; individual clinicians and a medical director aren't named on the site
- Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Is NextMeds worth it? Our verdict
NextMeds positions itself around one thing: flat-price compounded GLP-1 bundled with a care coach and dietitian. It runs $129/month, flat across every dose — toward the affordable end of the market. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
On top of the prescription itself, NextMeds points to Coach + dietitian, Flat price, every dose, and No insurance, FSA.
How much NextMeds actually costs
- Compounded semaglutide — $129/month
- Compounded tirzepatide — $179/month
That puts NextMeds below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
Live Vital (about $130/month) is one of the closest alternatives to weigh NextMeds against.
Medications: what NextMeds prescribes
NextMeds prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who NextMeds is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- want coaching and follow-up included, not sold separately.
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
NextMeds treats patients in all 50 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
NextMeds earns its place on the shortlist mainly on price: at $129/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
NextMeds scores highest on state availability and ease of access.
Ready to start with NextMeds?
Starting at $129/month. See current pricing and start your free consultation.
NextMeds might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this NextMeds review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See NextMeds's current pricing
Plans start at $129/month. Start your free consultation to check eligibility and today's price.